Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 7294040

Evaluating antimicrobial use with an algorithm.

S C Hurley
View original source ↗Export metadata ↓

Abstract

An algorithm (integrated series of screening criteria) for evaluating antimicrobial use is described. The algorithm was initially designed during a survey of the antimicrobial use for 117 patients. After the survey, the criteria in the algorithm were refined by a literature search; 10 criteria in the algorithm were added, six of which concerned the prophylactic use of antimicrobials. Two hospitals used the algorithm and reported that it reduced the number of hours needed to establish final audit criteria.

Explore related subjects

Anti-Infective AgentsBacterial InfectionsDrug UtilizationEvaluation Studies as TopicHumansResearch DesignStatistics as TopicJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S C Hurley. 1981. Evaluating antimicrobial use with an algorithm.. https://pubmed.ncbi.nlm.nih.gov/7294040/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium.

In order to study the role of gyrB in antibiotic resistance in post-ciprofloxacin therapy fluoroquinolone-resistant clinical isolates of Salmonella typhimurium, plasmid pBP548, which contains the Escherichia coli gyrB gene, was used in complementation studies. In a heterodiploid strain, the wild-type (quinolone sensitive) allele is dominant over the resistant allele therefore, eleven clinical isolates were complemented with gyrB encoded on pBP548. Only one transformant, L18pBP548, exhibited increased susceptibility to the quinolones nalidixic acid, ciprofloxacin and sparfloxacin. The amino acid sequence of the gyrase B protein from a wild-type and the pre-therapy S. typhimurium (deduced from the nucleotide sequence) was identical to that of E. coli from codons 436 to 470; however, a point mutation was identified in codon 463 of gyrB of the quinolone-resistant post-therapy isolate L18, giving rise to an amino acid substitution of serine to tyrosine.

Anti-Infective Agents↗